Value in Health

Published by: Elsevier Science, Inc.  

People

  1. D'Angelo
    D'Angelo
  2. Chi
    Chi
  3. Tap
    Tap

Groups

  1. Department of Medicine (4)
  2. Sarcoma Service (4)
  3. Solid Tumor Oncology Division (4)
  4. Hematologic Malignancies, Division of (2)
  5. GSK Faculty (1)
  6. Human Oncology and Pathogenesis Program (1)
  7. Tow Center for Developmental Oncology (TCDO) (1)
Search Within
  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (4)
Groups
  1. Department of Medicine (4)
  2. Sarcoma Service (4)
  3. Solid Tumor Oncology Division (4)
  4. Hematologic Malignancies, Division of (2)
  5. GSK Faculty (1)
  6. Human Oncology and Pathogenesis Program (1)

More Groups

People
  1. Sandra D'Angelo (2)
  2. Ping Chi (1)
  3. William Tap (1)
Years
  1. 2022 (2)
  2. 2020 (1)
  3. 2017 (1)
Publishers
  1. Elsevier Science, Inc. (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient-reported outcomes following treatment with vimseltinib for tenosynovial giant cell tumour in a phase 2 expansion study
    Meeting Abstract

    Blay, J. Y.; Gelderblom, H.; Rutkowski, P.; Wagner, A. J.; van de Sande, M.; Stacchiotti, S.; Le Cesne, A.; Palmerini, E.; Vallee, M.; Harrow, B.; more...
    Value in Health (2022)

    Fulltext@MSK | Save
  • Health state utility values and quality of life in patients receiving ripretinib in the phase 3 INVICTUS trial and a real-world evidence study in China
    Meeting Abstract

    Jones, R. L.; Blay, J. Y.; Chi, P.; Bauer, S.; Gelderblom, H.; Shen, L.; He, Y. L.; Heinrich, M. C.; Schöffski, P.; Zalcberg, J. R.; more...
    Value in Health (2022)

    Fulltext@MSK | Save
  • Comparing patient-relevant endpoint with clinical endpoint in a rare disease: The case of metastatic Merkel cell carcinoma treated with avelumab
    Meeting Abstract

    Bharmal, M.; Nolte, S.; Lebbe, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Pusceddu, S.; Hanna, G. J.; Hassel, J. C.; more...
    Value in Health (2020)

    Fulltext@MSK | Save
  • Budget impact analysis of avelumab in patients with metastatic Merkel cell carcinoma in the US
    Meeting Abstract

    Bharmal, M.; D'Angelo, S. P.; Phatak, H.
    Value in Health (2017)

    Fulltext@MSK | Save

    • Value in Health – authorized name for:

    Name ISSN / ISBN Publisher
    Value in Health 10983015 International Society for Pharmacoeconomics and Outcomes Research (ispor)
    Value in Health 10983015 International Society for Pharmacoeconomics and Outcomes Research, Inc
    Value in Health 1098-3015 Elsevier Science, Inc.
    Value in Health 10983015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
    Value in Health 1098-3015 Unknown
    Value in Health 1098-3015 Elsevier Science, Inc.
    Value in Health 1098-3015 Elsevier B.V.
    Value in Health 10983015 2023
    Value in Health 10983015 Ispor–the Professional Society for Health Economics and Outcomes Research
    Value in Health 1098-3015 Blackwell Publishing
    Value in Health 1098-3015 Elsevier Science, Inc.
    Value in Health 1098-3015 Elsevier B.V.
    Value in Health 1098-3015 Elsevier Science, Inc.
    Value in Health 10983015 Unknown